127 related articles for article (PubMed ID: 20938419)
21. Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2 years.
Paz-Filho GJ; Mesa CO; Carvalho GA; Goedert CA; Graf H
Clin Endocrinol (Oxf); 2008 Aug; 69(2):345-6. PubMed ID: 18167135
[No Abstract] [Full Text] [Related]
22. Effect of recombinant human TSH on the uptake of radioactive iodine ((123)I) by the thyroid gland in healthy beagles.
Campos M; Peremans K; Duchateau L; Dobbeleir A; Vandermeulen E; van Hoek I; Paes G; Daminet S
Domest Anim Endocrinol; 2010 Nov; 39(4):215-21. PubMed ID: 20688462
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial.
Nielsen VE; Bonnema SJ; Boel-Jørgensen H; Veje A; Hegedüs L
J Clin Endocrinol Metab; 2005 Jan; 90(1):79-83. PubMed ID: 15494456
[TBL] [Abstract][Full Text] [Related]
24. Radioiodine - an attractive alternative to surgery in large non-toxic multinodular goitres.
Kaniuka S; Lass P; Sworczak K
Nucl Med Rev Cent East Eur; 2009; 12(1):23-9. PubMed ID: 19554518
[TBL] [Abstract][Full Text] [Related]
25. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human thyrotropin before (131)I therapy in patients with nodular goitre: a meta-analysis of randomized controlled trials.
Lee YY; Tam KW; Lin YM; Leu WJ; Chang JC; Hsiao CL; Hsu MT; Hsieh AT
Clin Endocrinol (Oxf); 2015 Nov; 83(5):702-10. PubMed ID: 25370124
[TBL] [Abstract][Full Text] [Related]
27. [The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter].
Jedrzejuk D; Milewicz A
Postepy Hig Med Dosw (Online); 2005 May; 59():188-92. PubMed ID: 15928602
[TBL] [Abstract][Full Text] [Related]
28. Prolonged follow-up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH.
Cardia MS; Rubio IG; Medeiros-Neto G
Clin Endocrinol (Oxf); 2006 Apr; 64(4):474. PubMed ID: 16584523
[No Abstract] [Full Text] [Related]
29. Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre.
Giusti M; Caorsi V; Mortara L; Caputo M; Monti E; Schiavo M; Bagnara MC; Minuto F; Bagnasco M
Endocrine; 2014 Mar; 45(2):221-9. PubMed ID: 23619962
[TBL] [Abstract][Full Text] [Related]
30. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
[TBL] [Abstract][Full Text] [Related]
31. The effects of recombinant human thyrotropin, in normal subjects and patients with goitre.
Nielsen VE; Bonnema SJ; Hegedüs L
Clin Endocrinol (Oxf); 2004 Dec; 61(6):655-63. PubMed ID: 15579178
[No Abstract] [Full Text] [Related]
32. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
[TBL] [Abstract][Full Text] [Related]
33. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
[TBL] [Abstract][Full Text] [Related]
34. [Does Iodine 131 treatment of goiter result in an acute increase of the volume and function of the thyroid gland?].
Nygaard B; Faber JO; Hegedüs L
Ugeskr Laeger; 1995 Dec; 157(50):7003-6. PubMed ID: 8545918
[TBL] [Abstract][Full Text] [Related]
35. Acute changes in thyroid volume and function following 131I therapy of multinodular goitre.
Nygaard B; Faber J; Hegedüs L
Clin Endocrinol (Oxf); 1994 Dec; 41(6):715-8. PubMed ID: 7889605
[TBL] [Abstract][Full Text] [Related]
36. Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter.
Woodmansee WW; Haugen BR
Clin Endocrinol (Oxf); 2004 Aug; 61(2):163-73. PubMed ID: 15272910
[TBL] [Abstract][Full Text] [Related]
37. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
38. [Long-term effect of 131I therapy of multinodular non-toxic goiter].
Nygaard B; Hegedüs L; Gervil M; Jensen HH; Søe-Jensen P; Hansen JE
Ugeskr Laeger; 1994 Sep; 156(39):5699-703. PubMed ID: 7985257
[TBL] [Abstract][Full Text] [Related]
39. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.
Pötzi C; Moameni A; Karanikas G; Preitfellner J; Becherer A; Pirich C; Dudczak R
Clin Endocrinol (Oxf); 2006 Oct; 65(4):519-23. PubMed ID: 16984246
[TBL] [Abstract][Full Text] [Related]
40. An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter.
Medeiros-Neto G; Marui S; Knobel M
Endocrine; 2008 Apr; 33(2):109-17. PubMed ID: 18491237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
